Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other neoplasm 1Dermatologic 1

Conditions

Precancerous Conditions 1Melanoma 1Inflammatory Bowel Diseases 1Hepatitis C 1Hematologic Neoplasms 1Granulomatous Disease, Chronic 1Fatigue 1Crohn Disease 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Ribavirin 3tremelimumab 1telaprevir 1peginterferon alfa-2a 1menatetrenone 1ledipasvir, sofosbuvir drug combination 1Sofosbuvir 1Infliximab 1Hypothermia, Induced 1Chromatography, High Pressure Liquid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Hepatitis C × Infliximab × Clear all
NCT00897312 2016-04-25

Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease

Vanderbilt-Ingram Cancer Center

Terminated
7 enrolled
DermatologicOther neoplasm

Hepatitis C, Melanoma, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡